Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD.AX)

Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Resmed Inc 9001 Spectrum Center Boulevard San Diego CA 92123 USA

https://www.resmed.com P: 858-836-5000

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Key Statistics

Overview:

Market Capitalization, $K 46,792,930
Shares Outstanding, K 1,456,784
% of Institutional Shareholders 10.60%

Financials:

Annual Sales, $ 5,146 M
Annual Net Income, $ 1,401 M
Last Quarter Sales, $ 1,423 M
Last Quarter Net Income, $ 392,593 K

Growth:

1-Year Return -8.14%
3-Year Return -1.21%
5-Year Return 26.03%
5-Year Revenue Growth 11.72%
5-Year Earnings Growth 17.37%
5-Year Dividend Growth 12.62%

Per-Share Information:

Most Recent Earnings 0.27 on 01/30/26
Next Earnings Date N/A
Earnings Per Share ttm 1.01
EPS Growth vs. Prev Qtr 13.08%
EPS Growth vs. Prev Year 0.37%
Annual Dividend & Yield (Paid) 0.23 (1.08%)
Annual Dividend & Yield (Fwd) 0.24 (1.08%)
Most Recent Dividend 0.060 on 02/11/26
Next Ex-Dividends Date 02/11/26
Dividend Payable Date 03/19/26
Dividend Payout Ratio 22.35%
Most Recent Split 2-1 on 08/12/10

RMD.AX Ratios

Ratio
Price/Earnings ttm 21.79
Price/Earnings forward 18.66
Return-on-Equity % 25.68%
Return-on-Assets % 19.00%
Profit Margin % 27.22%
Debt/Equity 0.14
Price/Sales 6.10
Price/Book 5.08
Book Value/Share 6.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.